Preferred Antibiotics for Oral Soft Tissue Infections
For oral soft tissue infections, cephalexin (500 mg 3-4 times daily for 5-6 days) is the first-line antibiotic treatment, with alternatives including clindamycin (300-450 mg three times daily) or amoxicillin-clavulanate (875/125 mg twice daily) for 5-7 days. 1
First-Line Treatment Options
Non-purulent Infections (Streptococcal/MSSA)
- Cephalexin: 500 mg 3-4 times daily for 5-6 days 1
- Dicloxacillin: 500 mg 4 times per day (oral agent of choice for methicillin-susceptible strains) 2
- Amoxicillin-clavulanate: 875/125 mg twice daily for 5-7 days 1
If Beta-lactam Allergy
- Clindamycin: 300-450 mg three times daily for 5-6 days 1
- Doxycycline: 100 mg twice daily for 5-6 days (not recommended for children under 8 years) 2, 1
Treatment Algorithm Based on Infection Severity
Mild Infections
- Oral therapy:
Moderate Infections
- Oral therapy with one of the following:
Severe Infections
- Intravenous therapy:
MRSA Coverage Considerations
Add MRSA coverage if:
- Previous MRSA infection
- Purulent drainage
- Systemic inflammatory response syndrome
- Penetrating trauma 1
MRSA Treatment Options
Oral:
Intravenous:
Special Considerations
Duration of Therapy
- Initial treatment should be 5-6 days 1
- Extend if infection has not improved within this period 1
- For infections involving bone or joint, longer therapy is required:
- 3-4 weeks for synovitis
- 4-6 weeks for osteomyelitis 1
Supportive Care
- Elevate affected area to reduce edema 1
- Ensure tetanus prophylaxis is current 1
- For abscesses, incision and drainage is essential - antibiotics alone are often insufficient 1
Common Pitfalls to Avoid
- Inadequate treatment duration - extend therapy if clinical response is inadequate 1
- Failure to drain purulent collections - antibiotics alone may be insufficient for abscesses 1
- Overuse of broad-spectrum antibiotics - reserve vancomycin and newer agents for severe infections or confirmed MRSA 1
- Failure to address predisposing factors - identify and treat underlying conditions to prevent recurrence 1
Recent evidence suggests that amoxicillin-clavulanate may be particularly effective for oral soft tissue infections due to its broad coverage of oral flora, including anaerobes 3. However, cephalexin remains the first-line treatment due to its excellent efficacy against the most common causative organisms and favorable side effect profile 1.